Log In
Print this Print this

anti-MARV siRNA, TKM-Marburg

  Manage Alerts
Collapse Summary General Information
Company Arbutus Biopharma Corp.
DescriptionRNAi therapeutic against Marburg virus formulated with Tekmira's lipid nanoparticle (LNP) siRNA delivery technology
Molecular Target
Mechanism of Action 
Therapeutic ModalityNucleic acid: Linear RNA: siRNA
Latest Stage of DevelopmentPreclinical
Standard IndicationViral infection
Indication DetailsTreat Marburg virus infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today